153 related articles for article (PubMed ID: 15000867)
1. T lymphocyte subsets and immunoglobulins in intracranial tumor patients before and after treatment, and based on histological type of tumors.
Kempuraj D; Devi RS; Madhappan B; Conti P; Nazer MY; Christodoulou S; Reginald J; Suthinthirarajan N; Namasivayam A
Int J Immunopathol Pharmacol; 2004; 17(1):57-64. PubMed ID: 15000867
[TBL] [Abstract][Full Text] [Related]
2. [Immunological monitoring of brain tumors--prognosis based on T-lymphocyte subpopulations and skin testing for delayed hypersensitivity].
Yokoyama H; Nakadai M; Asou Y; Maeda T; Ogashiwa M; Takeuchi K
No To Shinkei; 1985 Feb; 37(2):193-9. PubMed ID: 3873952
[TBL] [Abstract][Full Text] [Related]
3. Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group.
Shearer WT; Easley KA; Goldfarb J; Rosenblatt HM; Jenson HB; Kovacs A; McIntosh K
J Allergy Clin Immunol; 2000 Sep; 106(3):559-66. PubMed ID: 10984378
[TBL] [Abstract][Full Text] [Related]
4. T cell adoptive immunotherapy of newly diagnosed gliomas.
Plautz GE; Miller DW; Barnett GH; Stevens GH; Maffett S; Kim J; Cohen PA; Shu S
Clin Cancer Res; 2000 Jun; 6(6):2209-18. PubMed ID: 10873070
[TBL] [Abstract][Full Text] [Related]
5. Capacity of sera from patients with primary intracranial tumors to support mitogen stimulation of blood lymphocytes. Correlation to histological tumor type.
Blomgren H; Blom U; Ullén H
Anticancer Res; 1985; 5(4):349-54. PubMed ID: 4037733
[TBL] [Abstract][Full Text] [Related]
6. Astrocytoma infiltrating lymphocytes include major T cell clonal expansions confined to the CD8 subset.
Perrin G; Schnuriger V; Quiquerez AL; Saas P; Pannetier C; de Tribolet N; Tiercy JM; Aubry JP; Dietrich PY; Walker PR
Int Immunol; 1999 Aug; 11(8):1337-50. PubMed ID: 10421791
[TBL] [Abstract][Full Text] [Related]
7. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.
Brooks WH; Netsky MG; Normansell DE; Horwitz DA
J Exp Med; 1972 Dec; 136(6):1631-47. PubMed ID: 4345108
[TBL] [Abstract][Full Text] [Related]
8. Differential chemosensitivity in human intracerebral gliomas measured by flow cytometric DNA analysis.
Iwadate Y; Fujimoto S; Yamaura A
Int J Mol Med; 2002 Aug; 10(2):187-92. PubMed ID: 12119557
[TBL] [Abstract][Full Text] [Related]
9. [Two-color flow cytometry analysis of lymphocyte subsets in patients with acute myocardial infarction and post-myocardial infarction syndrome].
Tsuchihashi M; Sakaguchi Y; Nakamura M; Sutani T; Tsuruta S; Kato S; Uemura S; Nishida Y; Hashimoto T; Kagoshima T
J Cardiol; 1995 Aug; 26(2):69-79. PubMed ID: 7674146
[TBL] [Abstract][Full Text] [Related]
10. A sequential scanning of the immune efficiency in astrocytoma (Grade I to Grade Iii), meningioma and secondary glioma patients with and without therapeutic scheduling.
Bhattacharjee M; Bose I; Sarkar P; Banerjee C; Dutta S; Ghosh A; Mukherjee J; Acharya S; Goswami S; Mazumdar A; Chaudhuri S; Chaudhuri S
Cancer Invest; 2006; 24(5):502-13. PubMed ID: 16939959
[TBL] [Abstract][Full Text] [Related]
11. [The mesenchymal defense reaction in the brain of the golden hamster after transplantation of human cerebral tumors].
Schmidt H; Kleinecke G; Goldenberg DM
Z Krebsforsch; 1968; 71(4):308-15. PubMed ID: 4304080
[No Abstract] [Full Text] [Related]
12. Lymphocytic infiltration in gliomas: evidence of possible host resistance.
Ridley A; Cavanagh JB
Brain; 1971; 94(1):117-24. PubMed ID: 5552158
[No Abstract] [Full Text] [Related]
13. Mitogen stimulation of blood lymphocytes from patients with primary intracranial tumors. Correlation to histological tumor type.
Blom U; Blomgren H; Ullén H; Collins P; Von Holst H
Anticancer Res; 1985; 5(4):343-8. PubMed ID: 4037732
[TBL] [Abstract][Full Text] [Related]
14. Changes in B and T-cell subsets and NMO-IgG levels after immunoglobulins and rituximab treatment for an acute attack of neuromyelitis optica.
de Andrés C; Teijeiro R; Saiz A; Fernández P; Sánchez-Ramón S
Neurologia; 2015 Jun; 30(5):276-82. PubMed ID: 24674779
[TBL] [Abstract][Full Text] [Related]
15. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells.
Tang J; Flomenberg P; Harshyne L; Kenyon L; Andrews DW
Clin Cancer Res; 2005 Jul; 11(14):5292-9. PubMed ID: 16033848
[TBL] [Abstract][Full Text] [Related]
16. Detection of circulating immune complexes associated with brain tumors. Correlation with histological differentiation and length of clinical history.
Lauro GM; Grossi M; Di Lorenzo N
Eur Neurol; 1983; 22(5):307-13. PubMed ID: 6628459
[TBL] [Abstract][Full Text] [Related]
17. Specificity of lymphocyte-mediated cytotoxicity in patients with primary intracranial tumors.
Levy NL
J Immunol; 1978 Sep; 121(3):903-15. PubMed ID: 211167
[No Abstract] [Full Text] [Related]
18. [Chemotherapy of malignant brain tumors].
Stieglmayr FS
Wien Med Wochenschr; 1973 Nov; 123(44):637-42. PubMed ID: 4584464
[No Abstract] [Full Text] [Related]
19. [Histoenzymological studies on cellular metabolism in intracranial tumors].
Brotchi J
Acta Neurol Belg; 1972; 72(1):5-17. PubMed ID: 5024250
[No Abstract] [Full Text] [Related]
20. A pilot study on the changes in immunity after ACTH therapy in patients with West syndrome.
Ohya T; Nagai T; Araki Y; Yanagawa T; Tanabe T; Iyoda K; Kurihara M; Yamamoto K; Masunaga K; Iizuka C; Nagamitsu S; Yamashita Y; Awaya Y; Maekawa K; Matsuishi T;
Brain Dev; 2009 Nov; 31(10):739-43. PubMed ID: 19118960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
